Skip to main content
×
×
Home

Treatment of psychosis in Parkinson's disease

  • Denise Duncan (a1) and David Taylor (a1)
Extract

Psychosis is often associated with Parkinson's disease. The cause of the psychosis cannot usually be confirmed but it may be due to disease progression or, more commonly, to the drugs used in the management of Parkinson's disease.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Treatment of psychosis in Parkinson's disease
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Treatment of psychosis in Parkinson's disease
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Treatment of psychosis in Parkinson's disease
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Ellis, C. M., Lemmens, G., Parker, J., et al (1995) Use of apomorphine in Parkinsonian patients with neuropsychiatric complications to oral treatment. Neurology, 45(Suppl. 4) A251.
Factor, S. A., Brown, D., Molho, E. S., et al (1994) Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis. Neurology, 44, 544546.
Ford, B., Lynch, T. & Greene, P. (1994) Risperidone in Parkinson's disease. Lancet, 344, 681.
Meco, G., Alessandria, A., Bonifati, V., et al (1994) Risperidone for hallucinations in levo-dopa-treated Parkinson's disease patients. Lancet, 343, 13701371.
Pfeiffer, C. & Wagner, M. L. (1994) Clozapine therapy for Parkinson's disease and other movement disorders. American Journal of Hospital Pharmacy, 51, 30473053.
Quinn, N. (1995) Drug treatment of Parkinson's disease. British Medical Journal, 310, 575579.
Rabey, J. M., Treves, T. A., Neufeld, M. Y., et al (1995) Low-dose clozapine in the treatment of levo-dopa-induced mental disturbances in Parkinson's disease. Neurology, 45, 432434.
Ray Chaudhuri, K., Abbott, R. J. & Millac, P. A. C. (1990) Subcutaneous apomorphine for Parkinsonian patients with psychiatric side-effects on oral treatment. Journal of Neurological and Neurosurgical Psychiatry, 54, 372373.
Wolters, E. C., Hurwtiz, T. A., Mak, E., et al (1990) Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis. Neurology, 40, 832834.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 5 *
Loading metrics...

Abstract views

Total abstract views: 15 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 16th July 2018. This data will be updated every 24 hours.

Treatment of psychosis in Parkinson's disease

  • Denise Duncan (a1) and David Taylor (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *